Introduction Endoscopic retrograde pancreatography (ERP) has traditionally been the
standard modality for pancreatic endotherapy. However, in certain situations, failure of …

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has emerged as an
effective and minimally invasive treatment for pancreatic lesions, particularly in patients at …

Insulinomas are the most common neoplasms of the endocrine pancreas in dogs, leading to
persistent hypoglycemia due to inappropriate insulin secretion. The standard treatment is …

The incidence and prevalence of pancreatic neuroendocrine neoplasms are steadily
increasing. These tumors are highly heterogeneous, with treatment options ranging from …

Objective Meta-analysis was used to assess the efficacy and safety of ultrasound-guided
radiofrequency ablation combined with transhepatic artery embolization chemotherapy for …

Introduction and importance: Even though insulinoma is the most frequent neuroendocrine
tumor, it represents only 2% of pancreatic 2% of all pancreatic neoplasms. Diagnosis is …

Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor prognostics and
substantial therapeutic challenges, with dismal survival rates. Tumor resistance in PDAC is …

Pancreatic neuroendocrine tumors (NETs) are uncommon (1%–2% of all pancreatic tumors)
with an incidence rate of≤ 1 case per 100,000 individuals per year.[1] The presentation can …

Pancreatic neuroendocrine tumors (PNETs) are rare endocrine tumors originating from
pancreatic cells, constituting 1-2% of pancreatic tumors. The incidence of PNETs has risen …